63 related articles for article (PubMed ID: 3347711)
1. Acute myocardial ischemia: MR imaging with Mn-TP.
Pflugfelder PW; Wendland MF; Holt WW; Quay SC; Worah D; Derugin N; Higgins CB
Radiology; 1988 Apr; 167(1):129-33. PubMed ID: 3347711
[TBL] [Abstract][Full Text] [Related]
2. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model.
Bremerich J; Saeed M; Arheden H; Higgins CB; Wendland MF
Radiology; 2000 Aug; 216(2):524-30. PubMed ID: 10924581
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate, Mn-DPDP.
Pomeroy OH; Wendland M; Wagner S; Derugin N; Holt WW; Rocklage SM; Quay S; Higgins CB
Invest Radiol; 1989 Jul; 24(7):531-6. PubMed ID: 2502502
[TBL] [Abstract][Full Text] [Related]
4. Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP--enhanced MR imaging.
Saeed M; Wagner S; Wendland MF; Derugin N; Finkbeiner WE; Higgins CB
Radiology; 1989 Jul; 172(1):59-64. PubMed ID: 2500678
[TBL] [Abstract][Full Text] [Related]
5. Manganese-enhanced magnetic resonance imaging in experimental spinal cord injury: correlation between T1-weighted changes and Mn(2+) concentrations.
Martirosyan NL; Bennett KM; Theodore N; Preul MC
Neurosurgery; 2010 Jan; 66(1):131-6. PubMed ID: 20023543
[TBL] [Abstract][Full Text] [Related]
6. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model.
Flacke S; Allen JS; Chia JM; Wible JH; Periasamy MP; Adams MD; Adzamli IK; Lorenz CH
Radiology; 2003 Mar; 226(3):731-8. PubMed ID: 12601183
[TBL] [Abstract][Full Text] [Related]
7. Reversible and irreversible injury in the reperfused myocardium: differentiation with contrast material-enhanced MR imaging.
Saeed M; Wendland MF; Takehara Y; Higgins CB
Radiology; 1990 Jun; 175(3):633-7. PubMed ID: 2111568
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA.
McNamara MT; Tscholakoff D; Revel D; Soulen R; Schechtmann N; Botvinick E; Higgins CB
Radiology; 1986 Mar; 158(3):765-9. PubMed ID: 3945751
[TBL] [Abstract][Full Text] [Related]
9. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.
Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB
AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611
[TBL] [Abstract][Full Text] [Related]
10. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
11. Preliminary evaluation of EVP 1001-1: a new cardiac-specific magnetic resonance contrast agent with kinetics suitable for steady-state imaging of the ischemic heart.
Storey P; Danias PG; Post M; Li W; Seoane PR; Harnish PP; Edelman RR; Prasad PV
Invest Radiol; 2003 Oct; 38(10):642-52. PubMed ID: 14501492
[TBL] [Abstract][Full Text] [Related]
12. In vivo nuclear magnetic resonance imaging of myocardial perfusion using the paramagnetic contrast agent manganese gluconate.
Schaefer S; Lange RA; Kulkarni PV; Katz J; Parkey RW; Willerson JT; Peshock RM
J Am Coll Cardiol; 1989 Aug; 14(2):472-80. PubMed ID: 2754132
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced MR delineation of stunned myocardium with administration of MnCl(2) in rats.
Krombach GA; Saeed M; Higgins CB; Novikov V; Wendland MF
Radiology; 2004 Jan; 230(1):183-90. PubMed ID: 14695393
[TBL] [Abstract][Full Text] [Related]
14. Demarcation of myocardial ischemia: magnetic susceptibility effect of contrast medium in MR imaging.
Saeed M; Wendland MF; Tomei E; Rocklage SM; Quay SC; Moseley ME; Wolfe C; Higgins CB
Radiology; 1989 Dec; 173(3):763-7. PubMed ID: 2813783
[TBL] [Abstract][Full Text] [Related]
15. MR imaging of reperfused myocardial infarction: comparison of necrosis-specific and intravascular contrast agents in a cat model.
Lee SS; Goo HW; Park SB; Lim CH; Gong G; Seo JB; Lim TH
Radiology; 2003 Mar; 226(3):739-47. PubMed ID: 12601203
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver.
Wisner ER; Merisko-Liversidge E; Kellar K; Katzberg RW; Karpinski PH; Amparo EG; Drake C; Griffey SM; Brock JM
Acad Radiol; 1995 Feb; 2(2):140-7. PubMed ID: 9419538
[TBL] [Abstract][Full Text] [Related]
17. Assessment of nicorandil therapy in ischemic myocardial injury by using contrast-enhanced and functional MR imaging.
Lund GK; Higgins CB; Wendland MF; Watzinger N; Weinmann HJ; Saeed M
Radiology; 2001 Dec; 221(3):676-82. PubMed ID: 11719662
[TBL] [Abstract][Full Text] [Related]
18. Gadomer-enhanced MR imaging in the detection of microvascular obstruction: alleviation with nicorandil therapy.
Krombach GA; Higgins CB; Chujo M; Saeed M
Radiology; 2005 Aug; 236(2):510-8. PubMed ID: 16040908
[TBL] [Abstract][Full Text] [Related]
19. Functional activity mapping of rat auditory pathway after intratympanic manganese administration.
Lee HJ; Yoo SJ; Lee S; Song HJ; Huh MI; Jin SU; Lee KY; Lee J; Cho JH; Chang Y
Neuroimage; 2012 Apr; 60(2):1046-54. PubMed ID: 22273568
[TBL] [Abstract][Full Text] [Related]
20. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.
Spuentrup E; Ruhl KM; Botnar RM; Wiethoff AJ; Buhl A; Jacques V; Greenfield MT; Krombach GA; Günther RW; Vangel MG; Caravan P
Circulation; 2009 Apr; 119(13):1768-75. PubMed ID: 19307474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]